These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 19935703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Miyazono K.
    Cancer Res; 2009 Apr 01; 69(7):2783-91. PubMed ID: 19293183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A.
    Oncogene; 2008 Feb 21; 27(9):1218-30. PubMed ID: 17724470
    [Abstract] [Full Text] [Related]

  • 7. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 8. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
    Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H, Shimizu K, Takehara K, Cano A, Saitoh M, Miyazono K.
    Cell Death Differ; 2004 Oct 15; 11(10):1092-101. PubMed ID: 15181457
    [Abstract] [Full Text] [Related]

  • 9. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 10. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.
    Gonzalez-Moreno O, Lecanda J, Green JE, Segura V, Catena R, Serrano D, Calvo A.
    Exp Cell Res; 2010 Feb 15; 316(4):554-67. PubMed ID: 20006606
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
    Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A.
    J Cell Biol; 2006 Jul 17; 174(2):175-83. PubMed ID: 16831886
    [Abstract] [Full Text] [Related]

  • 12. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
    Respir Res; 2005 Jun 09; 6(1):56. PubMed ID: 15946381
    [Abstract] [Full Text] [Related]

  • 13. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.
    Clin Cancer Res; 2009 May 15; 15(10):3557-67. PubMed ID: 19447876
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
    Räsänen K, Vaheri A.
    J Dermatol Sci; 2010 May 15; 58(2):97-104. PubMed ID: 20399617
    [Abstract] [Full Text] [Related]

  • 15. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
    Jungert K, Buck A, von Wichert G, Adler G, König A, Buchholz M, Gress TM, Ellenrieder V.
    Cancer Res; 2007 Feb 15; 67(4):1563-70. PubMed ID: 17308095
    [Abstract] [Full Text] [Related]

  • 16. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 15; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, Chan JL, Liu F, Chu TT, Wang LH.
    Oncogene; 2008 Apr 17; 27(18):2626-34. PubMed ID: 17982486
    [Abstract] [Full Text] [Related]

  • 18. Follistatin antagonizes transforming growth factor-beta3-induced epithelial-mesenchymal transition in vitro: implications for murine palatal development supported by microarray analysis.
    Nogai H, Rosowski M, Grün J, Rietz A, Debus N, Schmidt G, Lauster C, Janitz M, Vortkamp A, Lauster R.
    Differentiation; 2008 Apr 17; 76(4):404-16. PubMed ID: 18028449
    [Abstract] [Full Text] [Related]

  • 19. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
    Lee HS, Kim C, Kim SB, Kim MG, Park D.
    Biochem Biophys Res Commun; 2010 May 14; 395(4):553-9. PubMed ID: 20398629
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
    Cancer Res; 2008 Mar 01; 68(5):1388-97. PubMed ID: 18316602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.